Impilo
All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.
- Tracked funds
- 1
- Reported volume
- €700m
- Latest public closing
- 3 Jun 2025
Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.
Stockholm-based private equity firm investing in healthcare businesses.
Focus: Healthcare-related businesses, including pharmaceuticals, medical technology and healthcare services
23 April 2024: Impilo reached the final close of Impilo Fund II at €700m, raised over seven months after its formal launch (company news).
Tracked funds
- 700.0
Acquires majority stakes in Nordic healthcare businesses across pharmaceuticals, medical technology, specialist pharmaceutical services and related healthcare services.
- Health & Bio
- Nordic lower mid-market
- Fund 2
- 3 Jun 2025
- Impilo